The most common method of diagnosing cancer in patients is by obtaining a sample of the suspect tissue and examining it under a microscope for the presence of obviously malignant cells. While this process is relatively easy when the location of the suspect tissue is known, it is not so easy when there is no readily identifiable tumor or pre-cancerous lesion. For example, to detect the presence of lung cancer from a sputum sample requires one or more relatively rare cancer cells to be present in the sample. Therefore patients having lung cancer may not be diagnosed properly if the sample does not accurately reflect the conditions of the lung.
Malignancy-associated changes (MACs) are subtle changes that are known to take place in the nuclei of apparently normal cells found near cancer tissue. In addition, MACs have been detected in tissue found near pre-cancerous lesions. Because the cells exhibiting MACs are more numerous than the malignant cells, MACs offer an additional way of diagnosing the presence of cancer, especially in cases where no cancerous cells can be located.
Despite the ability of researchers to detect MACs in patients known to have cancer or a pre-cancerous condition, MACs have not yet achieved wide acceptance as a screening tool to determine whether a patient has or will develop cancer. Traditionally, MACs have been detected by carefully selecting a cell sample from a location near a tumor or pre-cancerous lesion and viewing the cells under relatively high magnification. However, it is believed that the malignancy-associated changes that take place in the cells are too subtle to be reliably detected by a human pathologist working with conventional microscopic equipment, especially when the pathologist does not know beforehand if the patient has cancer or not. For example, a malignancy-associated change may be indicated by the distribution of DNA within the nucleus coupled with slight variations in the shape of the nucleus edge. However, nuclei from normal cells may exhibit similar types of changes but not to the degree that would signify a MAC. Because human operators cannot easily quantify such subtle cell changes, it is difficult to determine which cells exhibit MACs. Furthermore, the changes which indicate a MAC may vary between different types of cancer, thereby increasing the difficulty of detecting them.
USPTO Backgrounds
USPTO Backgrounds